Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJade Road Inv Regulatory News (JADE)

Share Price Information for Jade Road Inv (JADE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.375
Bid: 1.25
Ask: 1.50
Change: 0.00 (0.00%)
Spread: 0.25 (20.00%)
Open: 1.375
High: 1.375
Low: 1.375
Prev. Close: 1.375
JADE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investment in Heirloom Litigation Finance

15 Nov 2023 07:56

RNS Number : 5284T
Jade Road Investments Limited
15 November 2023
 

15 November 2023

 

JADE ROAD INVESTMENTS LIMITED

("Jade Road Investments", "JADE" or the "Company")

 

Investment in Heirloom Litigation Finance

 

Jade Road Investments Limited (AIM: JADE), the London quoted company focused on seeking the best risk-adjusted returns globally, announces a new investment of $250,000 into Heirloom Litigation Funding 2022 SPV XI ("Heirloom Litigation Finance"). The investment was made in support of JADE's updated Investment Policy to invest in attractive, uncorrelated, risk adjusted return opportunities.

This is the second investment made by JADE under its new Investment Policy approved in February 2023. Its first investment, in April 2023, was into an Alternatives fund which invests primarily in asset-backed and/or income-producing opportunities such as equipment leasing, agriculture and infrastructure, and that are highly uncorrelated to the general market. 

Heirloom Litigation Finance has issued JADE a 1-year, 14% cash interest debt note, that is backed by a diversified portfolio of disbursement fundings for small consumer litigation claims in the UK, all backed by insurance. Interest is paid quarterly. Unlike many litigation finance opportunities, these claims fall under established precedents or quasi-governmental compensation programs, which are expected to increase the chance of success and reduce the length of time to settlement. The investment is a related party transaction under the Aim rules for Companies as Heirloom Investment Management LLC is a substantial shareholder in the Company and Heirloom Litigation Finance is a self-managed Cayman Islands company wholly owned by Heirloom Holdings. The Directors of the Company consider, having consulted with WH Ireland Limited, the Company's nominated adviser, that the terms of the transactions are fair and reasonable insofar as its shareholders are concerned.

JADE recognizes the importance of genuine diversification in this volatile market, and how alternative investing can reduce volatility and improve returns in an investment portfolio. JADE is pleased to add another investment that would be difficult for most investors to either access or diligence, and which aims to provide genuine diversification and risk-adjusted return enhancement to an investor's portfolio.

 John Croft, the Company's Executive Chairman, commented:

"JADE's investment in Heirloom Litigation Funding 2022 SPV XI continues to build on our updated Investment Policy and our commitment to providing our shareholders with a portfolio of investments with solid risk-adjusted global returns. With its strong return profile, insurance -backing, short duration and high coupon, which is paid quarterly, the Heirloom Litigation Finance investment is another step forward in JADE's on-going transformation." 

 

 

FOR FURTHER INFORMATION, PLEASE CONTACT:

 

Jade Road Investments Limited

+44 (0) 778 531 5588

John Croft

WH Ireland Limited - Nominated Adviser

+44 (0) 20 7220 1666

James Joyce

Andrew de Andrade

Hybridan LLP - Corporate Broker

+44 (0) 203 764 2341

Claire Noyce

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDUVVBROOUAARA
12
Date   Source Headline
1st May 20244:28 pmRNS2023 AGM Voting Results
8th Apr 20244:23 pmRNSPosting of Circular and Notice of AGM
3rd Apr 20243:58 pmRNSUpdates on Disposal of Legacy Assets
22nd Jan 20247:00 amRNSWebsite Update: Company Presentation and Q&A
5th Jan 20247:00 amRNSInvestor Meet Company Presentation
2nd Jan 20247:00 amRNSProposed Disposal of Legacy Assets & Restructuring
13th Dec 20237:00 amRNSOperational Update
15th Nov 20237:56 amRNSInvestment in Heirloom Litigation Finance
29th Sep 20237:00 amRNSINTERIM RESULTS FOR SIX MONTHS ENDED 30 JUNE 2023
4th Sep 20237:00 amRNSPlacement of Shares
25th Aug 202311:56 amRNSPlacement of shares
26th Jul 20232:10 pmRNSSecond Supplemental Bond Instrument Update
17th Jul 202311:37 amRNSUpdate on Interest Payment to Bondholders
3rd Jul 20235:45 pmRNSBond Interest Payment Update, Proposed Fundraising
26th May 20232:06 pmRNS2022 AGM Voting Results
26th May 20231:16 pmRNSFinal Results
9th May 20237:00 amRNSCorrection: Finding a Genuine Alternative
5th May 20231:57 pmRNSFinding a Genuine Alternative
5th Apr 20237:00 amRNSNew Investment
27th Mar 20237:00 amRNSRevision to Investment Management Agreement
24th Mar 202310:56 amRNSBoard Change
13th Mar 20234:40 pmRNSSecond Price Monitoring Extn
13th Mar 20234:35 pmRNSPrice Monitoring Extension
6th Mar 20234:40 pmRNSSecond Price Monitoring Extn
6th Mar 20234:35 pmRNSPrice Monitoring Extension
21st Feb 20237:00 amRNSResults of General Meeting
20th Feb 20237:00 amRNSCompletion of Conditional Equity Fundraise
31st Jan 20233:45 pmRNSReplacement Circular
31st Jan 20238:44 amRNSCirc re. Investing Policy, Proposed Placing & GM
1st Dec 202211:19 amRNSUS Dollar-denominated Corporate Bonds
21st Oct 20227:42 amRNSUS Dollar-denominated corporate bonds
22nd Sep 202211:59 amRNSINTERIM RESULTS FOR SIX MONTHS ENDED 30 JUNE 2022
18th Aug 20224:41 pmRNSSecond Price Monitoring Extn
18th Aug 20224:35 pmRNSPrice Monitoring Extension
18th Aug 20222:28 pmRNSPartial Divestment in Meize Energy Industries
17th Aug 20229:05 amRNSSecond Price Monitoring Extn
17th Aug 20229:00 amRNSPrice Monitoring Extension
1st Aug 202211:05 amRNSSecond Price Monitoring Extn
1st Aug 202211:00 amRNSPrice Monitoring Extension
1st Aug 20229:05 amRNSSecond Price Monitoring Extn
1st Aug 20229:00 amRNSPrice Monitoring Extension
20th Jul 20228:36 amRNSPartial Divestment in Meize Energy Industries
1st Jul 202210:29 amRNSReplacement for Final Results
30th Jun 20227:00 amRNSFinal Results
22nd Jun 20227:39 amRNSPartial divestment in Meize Energy Industries
20th May 20224:41 pmRNSSecond Price Monitoring Extn
20th May 20224:36 pmRNSPrice Monitoring Extension
17th Dec 20219:06 amRNSSecond Price Monitoring Extn
17th Dec 20219:00 amRNSPrice Monitoring Extension
17th Dec 20217:00 amRNSUPDATE ON FOOK LAM MOON HOLDINGS
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.